Bioclavis Limited
Private Limited Company · Clydebank
ActiveUnited KingdomIncorporated 2017Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2024-12-31
IXBRL · 111 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2024-12-31
IXBRL · 111 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 77
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2509_SC575642_20241231
- Source archive
- Accounts_Monthly_Data-September2025.zip
Accounts to 2023-12-31
IXBRL · 126 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 126 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 87
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2022-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2366_SC575642_20231231
- Source archive
- Accounts_Monthly_Data-July2024.zip
Accounts to 2022-12-31
IXBRL · 124 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 124 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2021-10-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 87
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0027_SC575642_20221231
- Source archive
- Accounts_Monthly_Data-September2023.zip
Accounts to 2021-09-30
IXBRL · 99 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2021-09-30
IXBRL · 99 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2020-10-01 to 2021-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 63
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0107_SC575642_20210930
- Source archive
- Accounts_Monthly_Data-June2022.zip
Accounts to 2020-09-30
IXBRL · 97 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2020-09-30
IXBRL · 97 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2019-10-01 to 2020-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 45
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0088_SC575642_20200930
- Source archive
- Accounts_Monthly_Data-March2021.zip
Accounts to 2019-09-30
IXBRL · 92 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2019-09-30
IXBRL · 92 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2018-10-01 to 2019-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 42
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0078_SC575642_20190930
- Source archive
- Accounts_Monthly_Data-May2020.zip
Accounts to 2018-09-30
IXBRL · 72 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2018-09-30
IXBRL · 72 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2017-09-06 to 2018-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 25
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0066_SC575642_20180930
- Source archive
- Accounts_Monthly_Data-May2019.zip
Registered details
SC575642- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2017-09-06
- Jurisdiction
- —
- Registered office
- 3CARUS HOUSE, DUMBARTON ROAD, CLYDEBANK, G81 4XJ, SCOTLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsRisk Stratification Tool for Colorectal Polyp SurveillanceInnovate UK · Collaborative R&D · 2023-04-01 – 2025-03-31 · with 3 other participants£213,347awarded
Risk Stratification Tool for Colorectal Polyp Surveillance
Innovate UK · Collaborative R&D · 2023-04-01 – 2025-03-31 · with 3 other participants
£213,347
awarded
University of Glasgowlead£1,376,830
Bioclavis Limited£213,347
Translation of TempO-Dx Expanded RASRAF Test markers onto liquid biopsy platform for monitoring treatment resistance in colorectal cancerLead
Innovate UK · Collaborative R&D · 2022-06-01 – 2024-07-31
£237,121
awarded
University of Glasgow and BioClavis LimitedInnovate UK · Knowledge Transfer Partnership · 2021-02-01 – 2023-04-30 · with 1 other participant
University of Glasgow and BioClavis Limited
Innovate UK · Knowledge Transfer Partnership · 2021-02-01 – 2023-04-30 · with 1 other participant
Bioclavis Limited—
The Living Laboratory: driving economic growth in Glasgow through real world implementation of precision medicineLiveInnovate UK · Collaborative R&D · 2020-10-01 – 2026-09-30 · with 9 other participants£521,650awarded
The Living Laboratory: driving economic growth in Glasgow through real world implementation of precision medicineLive
Innovate UK · Collaborative R&D · 2020-10-01 – 2026-09-30 · with 9 other participants
£521,650
awarded
NHS Ggc£3,377,557
Bioclavis Limited£521,650
Precision Medicine Scotland - Innovation Centre£7,222
Thermo Fisher Scientific£0
Integrated Technologies for Improved Polyp Surveillance (INCISE)Innovate UK · Collaborative R&D · 2020-02-01 – 2023-07-31 · with 4 other participants£460,197awarded
Integrated Technologies for Improved Polyp Surveillance (INCISE)
Innovate UK · Collaborative R&D · 2020-02-01 – 2023-07-31 · with 4 other participants
£460,197
awarded
Bioclavis Limited£460,197
NHS Greater Glasgow and Clyde£303,477
Integrated Technologies for Improved Polyp Surveillance (INCISE)ISCF · Collaborative R&D · 2020-02-01 – 2023-07-30 · with 4 other participants£2,349,970whole project
Integrated Technologies for Improved Polyp Surveillance (INCISE)
ISCF · Collaborative R&D · 2020-02-01 – 2023-07-30 · with 4 other participants
£2,349,970
whole project
University Of GlasgowleadBioclavis LimitedCanon Medical Research Europe, LimitedNHS Greater Glasgow And ClydeOraclebio Limited
Glasgow Molecular Pathology (GMP) NodeMRC · Research Grant · 2015-11-01 – 2019-10-31 · with 17 other participants£3,430,425whole project
Glasgow Molecular Pathology (GMP) Node
MRC · Research Grant · 2015-11-01 – 2019-10-31 · with 17 other participants
£3,430,425
whole project
University of GlasgowleadAridhiaAridhia Informatics LimitedBioClavis LtdEast Midlands Breathomics Pathology NodeEdinburgh-St Andrews Consortium for Molecular Pathology NodeGlasgow Royal InfirmaryIllumina Inc.Leica BiosystemsNational Cancer Research Institute (NCRI)Newcastle Molecular Pathology NodeNHS Greater Glasgow and Clyde (NHSGGC)Nottingham Molecular Pathology NodeSistemic LtdSistemic Scotland LtdStratified Medicine Scotland Innovation CentreThermo Fisher ScientificUniversity Of Manchester